Clinical Trials · NCT04307797
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Enrollment
- 10
- Start date
- Jan 2022
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Part A - Myocardial glucose uptake